SEC Tracker
Get the app

Verastem VSTM

Verastem, Inc. entered into an exchange agreement with Biotechnology Value Fund, L.P.

Form
8-K
Filed
Period
Importance
Notable
Document
8-K
Exhibit 10.1
Material contract
  • Sells unregistered shares (3.02)
  • Amends its charter or bylaws (5.03)

Not explained yet; the original is on EDGAR.

View on EDGAR

Open in the app

Get an email when Verastem files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.

  1. Corvus Pharmaceuticals CRVS public float $252M, Jun 30, 2025
  2. DBV Technologies DBVT public float $251M, Jun 30, 2025
  3. Atea Pharmaceuticals AVIR public float $263M, Jun 30, 2025
  4. Annexon ANNX public float $244M, Jun 30, 2025
  5. Vanda Pharmaceuticals VNDA public float $269M, Jun 30, 2025